Federal Circuit Reluctantly Applies Arthrex Decision, PTAB Litigation Blog
Visit the PTAB Litigation Blog.
On January 31, 2020, the Federal Circuit vacated and remanded a Patent Trial and Appeal Board ("PTAB") final written decision in view of Arthrex, but did so reluctantly because it disagreed with the merits and questioned the remedy of the Arthrex panel decision.
Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
